Tuberculosis Clinical Trials in Beijing, Beijing Municipality
7 recruitingBeijing, Beijing Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 4
Asymptomatic TB With Innovative Modified Short-course Regimens
Tuberculosis
Huashan Hospital426 enrolled5 locationsNCT06153069
Recruiting
Phase 3
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc.532 enrolled33 locationsNCT07209761
Recruiting
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
LymphomaLymphnode MetastasisLymphadenopathy+1 more
Peking University Third Hospital779 enrolled1 locationNCT07155954
Recruiting
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
Tuberculosis
Chengdu CoenBiotech Co., Ltd1,784 enrolled8 locationsNCT07152639
Recruiting
Phase 3
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd450 enrolled2 locationsNCT05824871
Recruiting
Phase 4
The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)
Pulmonary Tuberculosis
Beijing Chest Hospital45 enrolled7 locationsNCT06476210
Recruiting
Phase 4
Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
TreatmentAdjuvantTuberculosis
Beijing Chest Hospital292 enrolled1 locationNCT06403943